A Study of SKLB1028 in Patients With Advanced Solid Tumor
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic
characteristics and preliminary efficacy of SKLB1028 in patients with advanced solid tumors.